


Healthcare News Roundup: Neuro
HSMN NewsFeed - 14 Mar 2013
Orthofix International Appoints Brad Mason as President and Chief Executive Officer
Orthofix International Appoints Brad Mason as President and Chief Executive Officer
HSMN NewsFeed - 13 Mar 2013
Hospital Acceptance of Vycor's Patented VBAS Minimally Invasive Neurosurgical Device Continues to Accelerate
Hospital Acceptance of Vycor's Patented VBAS Minimally Invasive Neurosurgical Device Continues to Accelerate
HSMN NewsFeed - 4 Mar 2013
TranS1 Inc. Announces Agreement to Acquire Baxano, Inc. and $17.2M Financing Commitment
TranS1 Inc. Announces Agreement to Acquire Baxano, Inc. and $17.2M Financing Commitment
HSMN NewsFeed - 28 Feb 2013
InVivo Therapeutics Submits Updated IDE to FDA to Begin Spinal Cord Injury Human Study
InVivo Therapeutics Submits Updated IDE to FDA to Begin Spinal Cord Injury Human Study
HSMN NewsFeed - 27 Feb 2013
Surgical Theater, LLC(TM) Receives FDA Clearance for Surgery Rehearsal Platform(TM)
Surgical Theater, LLC(TM) Receives FDA Clearance for Surgery Rehearsal Platform(TM)
HSMN NewsFeed - 26 Feb 2013
FDA Advisory Panel Recommends Approval of the NeuroPace RNS(R) System for Medically Refractory Epilepsy
FDA Advisory Panel Recommends Approval of the NeuroPace RNS(R) System for Medically Refractory Epilepsy
HSMN NewsFeed - 19 Feb 2013
Independent Study Demonstrates Clinical Advantages Of Kiva(R) Over Balloon Kyphoplasty
Independent Study Demonstrates Clinical Advantages Of Kiva(R) Over Balloon Kyphoplasty
HSMN NewsFeed - 28 Jan 2013
BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer
BrainStorm Cell Therapeutics Appoints Alon Natanson as Chief Executive Officer
HSMN NewsFeed - 28 Jan 2013
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
Genzyme’s LEMTRADA(TM) (alemtuzumab) Application for MS Accepted for Review by the FDA
